Ignite Creation Date:
2025-12-18 @ 9:57 AM
Ignite Modification Date:
2025-12-23 @ 5:47 PM
Study NCT ID:
NCT05916014
Status:
None
Last Update Posted:
2024-04-12 00:00:00
First Post:
2023-06-14 00:00:00
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
AI-assisted White Light Endoscopy to Identify the Kimura-Takemoto Classification of Atrophic Gastritis
Sponsor:
None
Organization:
Study Overview
Official Title:
Artificial Intelligence-assisted White Light Endoscopy to Identify the Kimura-Takemoto Classification of Atrophic Gastritis to Achieve Gastric Cancer Risk Assessment
Status:
None
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Grading endoscopic atrophy according to the Kimura-Takemoto classification can assess the risk of gastric neoplasia development. The higher the score, the more severe the degree of atrophic gastritis. However, the false negative rate of chronic atrophic gastritis is high due to the varying diagnostic standardization and diagnostic experience and levels of endoscopists. Therefore, this study aims to develop an AI model to identify the Kimura-Takemoto classification of atrophic gastritis to achieve gastric cancer risk assessment.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: